# Arranon

NDC: 0078-0683
Generic name: nelarabine
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20161005
Marketing ended: 20260930
FDA application: NDA021877

## Active ingredients

- NELARABINE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0683"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0683
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fffa5d75-0dba-4ad7-a252-5f60fa28489a